Wehave previously reported the synthesis of 3' ' , 4/-dideoxy derivatives of neaminei;>, kanamycin B2) and ribostamycin3), which were active against kanamycin-resistant bacteria.
No takes yet. Share an insight, caveat, or question.
Takagi et al. (1973) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: